Finally, in 40% (10/25) of CML patients, evaluated by GeneXpert as BCR-ABL1 negative, dPCR was able to detect BCR-ABL1 transcript (Supplementary Table 7). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.